The guidelines have stressed the use of wearing masks, physical distancing and hand hygiene
07 Jun 2021 3:06 PM
R-Pharm’s announcement is another sign Russia is pushing hard to take a global lead in the race against the virus
19 Sep 2020 1:11 PM
The launch is part of a global licensing agreement with Fujifilm Chemical that grants exclusive rights to manufacture and sell tablets
19 Aug 2020 1:44 PM
The product is available from July 29 at all retail medical outlets across the country and will be sold only on prescription, it said
29 Jul 2020 2:04 PM
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
23 Jul 2020 9:40 AM
Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients
21 Jul 2020 3:38 PM
CEO of Biophore said all starting materials for making favipiravir are either sourced locally or have been developed in-house for use
15 Jul 2020 6:59 AM
Glenmark Pharmaceuticals had launched antiviral drug Favipiravir, under the brand name FabiFlu, last month at a price of Rs 103 per tablet
13 Jul 2020 2:53 PM
Slowing new infections has led to a shortage of patients to enroll in trials, which are underway for more than a dozen potential vaccines
24 Jun 2020 12:17 PM
Glenmark is already conducting clinical trials in India of just favipiravir as a potential treatment for COVID-19
26 May 2020 12:28 PM